Interviews with Key Healthcare Opinion Leaders - Episode #74

By Tamara Thomas - Last Updated: April 5, 2024

Andrew Hertler, MD, talks about the importance of prophylactic mastectomy for individuals carrying high-risk BRCA1, BRCA2, and other deleterious gene mutations.

Advertisement

Related Podcasts

Interviews with Key Healthcare Opinion Leaders - Episode #86
Interviews with Key Healthcare Opinion Leaders - Episode #85
Interviews with Key Healthcare Opinion Leaders - Episode #84
Interviews with Key Healthcare Opinion Leaders - Episode #83
Interviews with Key Healthcare Opinion Leaders – Episode #82
Advertisement
Advertisement
Latest News

Drs. Julie Schulz and Michael Dovidio on Using Lab Values for GLP-1 Drug Coverage

November 21, 2024

Black Patients With Cancer Report Spirituality, Distrust Influence Decision to Join Clinical Trials

November 20, 2024

Menopause Timing Could Contribute to Muscle Loss in Later Life, Study Finds

November 20, 2024

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • Who We Are

    About Us

    Editorial Policy

    Contributors & Partners

    Connect

    eNewsletters

    Contact Us

    Work With Us

    Advertising

    Our Network

    GU Oncology Now

    Blood Cancers Today

    Cancer Nursing Today

    DocWire News

    MashupMD

    © 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy